drug · small molecule
cantharidin
Marketedupdated 3mo agoby $VRCA Verrica Pharmaceuticals Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for molluscum contagiosum and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Trials studying cantharidin
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 21, 2028
~1.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Feb 19, 2041formulationUS 12290651
- Aug 22, 2038formulationUS 11147790
- Aug 22, 2038formulationUS 12233042
- May 28, 2035formulationUS 11052064
FDA exclusivities (1)
- Jul 21, 2028NCENew Chemical Entity (5y)1.9y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 25m ago
Found something off?
comments(0)
5-min edit window · permanent after that